Invention Grant
US09586965B2 Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
有权
吡咯并[2,3-d]嘧啶化合物作为蛋白激酶的抑制剂
![Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases](/docs/US/2017-03-07/US09586965B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
- Patent Title (中): 吡咯并[2,3-d]嘧啶化合物作为蛋白激酶的抑制剂
-
Application No.: US14420341Application Date: 2013-07-11
-
Publication No.: US09586965B2Publication Date: 2017-03-07
- Inventor: Xiao Xu , Xiaobo Wang , Long Mao , Li Zhao , Biao Xi
- Applicant: ACEA BIOSCIENCES INC.
- Applicant Address: US CA San Diego
- Assignee: ACEA BIOSCIENCES INC.
- Current Assignee: ACEA BIOSCIENCES INC.
- Current Assignee Address: US CA San Diego
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2013/050163 WO 20130711
- International Announcement: WO2014/025486 WO 20140213
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61K45/06 ; A61P35/00 ; A61P29/00 ; A61P17/06
![Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases](/abs-image/US/2017/03/07/US09586965B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to certain pyrrolopyrimidine derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3(D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways.
Public/Granted literature
- US20150210702A1 NOVEL PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES Public/Granted day:2015-07-30
Information query
